X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (673) 673
science & technology (665) 665
life sciences & biomedicine (657) 657
male (516) 516
female (489) 489
middle aged (392) 392
adult (380) 380
esomeprazole - administration & dosage (369) 369
esomeprazole (355) 355
pharmacology & pharmacy (295) 295
gastroenterology & hepatology (292) 292
treatment outcome (268) 268
aged (262) 262
proton pump inhibitors (242) 242
esomeprazole - therapeutic use (237) 237
anti-ulcer agents - administration & dosage (187) 187
gastroesophageal reflux - drug therapy (169) 169
proton pump inhibitors - administration & dosage (165) 165
esomeprazole - adverse effects (149) 149
drug therapy, combination (146) 146
anti-ulcer agents - therapeutic use (138) 138
omeprazole (138) 138
proton pump inhibitors - therapeutic use (134) 134
helicobacter infections - drug therapy (128) 128
helicobacter pylori (123) 123
double-blind method (122) 122
drug administration schedule (122) 122
dose-response relationship, drug (118) 118
adolescent (114) 114
gastroesophageal reflux (112) 112
prospective studies (109) 109
young adult (106) 106
proton pump inhibitors - adverse effects (93) 93
administration, oral (90) 90
cross-over studies (88) 88
medicine & public health (88) 88
esomeprazole - pharmacology (87) 87
aged, 80 and over (86) 86
lansoprazole (85) 85
hydrogen-ion concentration (82) 82
internal medicine (80) 80
drug therapy (79) 79
care and treatment (78) 78
proton pump inhibitor (78) 78
rabeprazole (77) 77
abridged index medicus (70) 70
esomeprazole - pharmacokinetics (70) 70
general & internal medicine (69) 69
anti-ulcer agents - adverse effects (67) 67
clinical trials (67) 67
helicobacter pylori - drug effects (67) 67
time factors (67) 67
amoxicillin - administration & dosage (66) 66
anti-bacterial agents - administration & dosage (66) 66
omeprazole - administration & dosage (65) 65
pharmacology/toxicology (65) 65
medicine, general & internal (64) 64
dosage and administration (62) 62
pharmacokinetics (62) 62
drug interactions (61) 61
2-pyridinylmethylsulfinylbenzimidazoles (57) 57
health aspects (57) 57
risk factors (57) 57
anti-bacterial agents - therapeutic use (55) 55
omeprazole - therapeutic use (54) 54
animals (53) 53
proton pump inhibitors - pharmacology (53) 53
analysis (52) 52
research (52) 52
anti-ulcer agents - pharmacology (51) 51
gastroesophageal reflux disease (51) 51
pantoprazole (51) 51
clarithromycin - administration & dosage (49) 49
follow-up studies (46) 46
pharmacotherapy (46) 46
amoxicillin - therapeutic use (45) 45
ulcers (44) 44
2-pyridinylmethylsulfinylbenzimidazoles - administration & dosage (43) 43
gastric acid - secretion (41) 41
gastric acidity determination (41) 41
peptic ulcer (41) 41
anti-ulcer agents - pharmacokinetics (39) 39
amoxicillin (38) 38
helicobacter infections - microbiology (38) 38
medical research (38) 38
proton pump inhibitors - pharmacokinetics (37) 37
severity of illness index (37) 37
pharmacology (36) 36
usage (36) 36
anti-bacterial agents - adverse effects (35) 35
endoscopy (35) 35
esophagitis, peptic - drug therapy (35) 35
area under curve (34) 34
breath tests (34) 34
medicine, experimental (34) 34
gastroesophageal reflux - complications (33) 33
retrospective studies (33) 33
aspirin (32) 32
gastroenterology (32) 32
gastroesophageal reflux - diagnosis (32) 32
more...
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (799) 799
Russian (8) 8
German (7) 7
French (4) 4
Japanese (4) 4
Chinese (3) 3
Spanish (3) 3
Swedish (3) 3
Korean (2) 2
Bulgarian (1) 1
Norwegian (1) 1
Portuguese (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


European journal of internal medicine, ISSN 0953-6205, 07/2016, Volume 32, pp. 84 - 90
Abstract Background Currently only a few studies compare sequential and concomitant non-bismuth Helicobacter pylori therapies referring to high antibiotic... 
Internal Medicine | H. pylori treatment | Sequential treatment | First line | Concomitant treatment | Metronidazole resistance | Clarithromycin resistance | Medicine, General & Internal | Life Sciences & Biomedicine | General & Internal Medicine | Science & Technology | Esomeprazole - administration & dosage | Humans | Middle Aged | Carbon Isotopes | Drug Resistance, Bacterial | Male | Helicobacter Infections - pathology | Helicobacter pylori | Peptic Ulcer - microbiology | Proton Pump Inhibitors - administration & dosage | Helicobacter Infections - drug therapy | Clarithromycin - administration & dosage | Adult | Female | Helicobacter Infections - metabolism | Urea - metabolism | Amoxicillin - administration & dosage | Drug Therapy, Combination | Dyspepsia - drug therapy | Metronidazole - administration & dosage | Breath Tests | Dyspepsia - microbiology | Pyloric Antrum - pathology | Biopsy | Aged | Anti-Bacterial Agents - administration & dosage | Peptic Ulcer - drug therapy | Clinical trials | Drug resistance in microorganisms | Clarithromycin | Index Medicus | Helicobacter Infections/drug therapy | Peptic Ulcer/drug therapy | Proton Pump Inhibitors/administration & dosage | Helicobacter Infections/pathology | Peptic Ulcer/microbiology | Tissues and Organs | Life Sciences | Esomeprazole/administration & dosage | Hépatology and Gastroenterology | Pyloric Antrum/pathology | Anti-Bacterial Agents/administration & dosage | Dyspepsia/microbiology | Helicobacter Infections/metabolism | Bacteriology | Clarithromycin/administration & dosage | Urea/metabolism | Metronidazole/administration & dosage | Microbiology and Parasitology | Human health and pathology | Amoxicillin/administration & dosage | Dyspepsia/drug therapy
Journal Article
The Lancet (British edition), ISSN 0140-6736, 06/2017, Volume 389, Issue 10087, pp. 2375 - 2382
Summary Background Present guidelines are conflicting for patients at high risk of both cardiovascular and gastrointestinal events who continue to require... 
Internal Medicine | Medicine, General & Internal | Life Sciences & Biomedicine | General & Internal Medicine | Science & Technology | Celecoxib - administration & dosage | Recurrence | Cardiovascular Diseases - drug therapy | Humans | Middle Aged | Secondary Prevention - methods | Aspirin - administration & dosage | Cyclooxygenase 2 Inhibitors - adverse effects | Proton Pump Inhibitors - administration & dosage | Aspirin - adverse effects | Naproxen - administration & dosage | Cyclooxygenase 2 Inhibitors - therapeutic use | Peptic Ulcer Hemorrhage - prevention & control | Aged, 80 and over | Aspirin - therapeutic use | Drug Therapy, Combination | Celecoxib - adverse effects | Naproxen - adverse effects | Proton Pump Inhibitors - adverse effects | Double-Blind Method | Drug Administration Schedule | Cyclooxygenase 2 Inhibitors - administration & dosage | Peptic Ulcer Hemorrhage - chemically induced | Celecoxib - therapeutic use | Proton Pump Inhibitors - therapeutic use | Naproxen - therapeutic use | Anti-Inflammatory Agents, Non-Steroidal - adverse effects | Anti-Inflammatory Agents, Non-Steroidal - therapeutic use | Anti-Inflammatory Agents, Non-Steroidal - administration & dosage | Arthritis - drug therapy | Aged | Care and treatment | Aspirin | Anti-inflammatory drugs | Gastrointestinal diseases | Naproxen | Clinical trials | Arthritis | Complications and side effects | Medical research | Gastrointestinal bleeding | Medicine, Experimental | Drugs | Funding | Risk | Population studies | Hemorrhage | Evidence-based medicine | Bleeding | Incidence | Motivation | Safety | Nonsteroidal anti-inflammatory drugs | Digestive system | Risk reduction | Inflammation | Celecoxib | Patients | Anti-inflammatory agents | Diseases | Omeprazole | Random numbers | Inhibitors | Ulcers | Healing | Fatalities | Cyclooxygenase-2 | Cardiovascular diseases | Health risk assessment | Protons | Randomization | Analgesics | Endoscopy | Drug dosages | Mortality | Health risks | Hospitals | Index Medicus | Abridged Index Medicus
Journal Article
Gastroenterology (New York, N.Y. 1943), ISSN 0016-5085, 01/2017, Volume 152, Issue 1, pp. 134 - 141
Journal Article
American Journal of Cardiology, The, ISSN 0002-9149, 2016, Volume 117, Issue 3, pp. 366 - 368
Journal Article
Digestion, ISSN 0012-2823, 01/2017, Volume 94, Issue 4, pp. 240 - 246
Journal Article
Journal Article
Journal Article
Journal Article